It has been reported that expression levels of STING and its downstream factors are significantly higher in diseased skin samples from psoriasis patients (compared with levels in skin samples from healthy people), These results reveal the potential involvement of STING dysregulation in the pathogenesis of psoriasis. The gene discussed is STING1; the disease is psoriasis.